New #Stocks to Watch at Investor Ideas in Biotech (CSE: $WESA.C) (Nasdaq: $LHDX) (Nasdaq: $VOR) and Mining (TSXV: $LOT.V) (TSXV: $CTM.V)

 New #Stocks to Watch at Investor Ideas in Biotech (CSE: $WESA.C) (Nasdaq: $LHDX) (Nasdaq: $VOR) and Mining (TSXV: $LOT.V) (TSXV: $CTM.V)

 

Also new stocks in Tech and Green Energy 

 

 

Point Roberts WA, Delta BC, May 14, 2021 – (Investorideas.com Newswire) Investorideas.com, a global news source and leading retail investor and trader resource, announces its weekly roundup of stocks to watch in Biotech, Mining, Tech and Green Energy. Today’s stocks have been added to our lists of free stock directories in each sector.

 

Read this in full at  https://www.investorideas.com/news/2021/main/05141Stocks.asp

 

The newest biotech companies are involved in biopharmaceuticals, life sciences, stem cell therapies, COVID test kits and traumatic brain injury treatment using psychedelic and naturally-sourced therapies.

 

The latest mining companies are all TSX Venture listed.

 

The newest tech company is involved in the semiconductor sector while the latest green energy company is involved in the production of biofuels.

 

New Stocks added to Biotech Stocks Directory:

Vor Biopharma Inc.(NasdaqGS:VOR) is a cell therapy company that aims to transform the lives of cancer patients by pioneering engineered hematopoietic stem cell (eHSC) therapies to create next-generation, treatment-resistant transplants that unlock the potential of targeted therapies. By removing biologically redundant proteins from eHSCs, we design these cells and their progeny to be treatment-resistant to complementary targeted therapies, thereby enabling these therapies to selectively destroy cancerous cells while sparing healthy cells.

 

Terns Pharmaceuticals, Inc. (NasdaqGS:TERN) is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. Terns’ programs are based on clinically validated and complementary mechanisms of action to address the multiple hepatic disease processes of NASH in order to drive meaningful clinical benefits for patients

 

Pharvaris N.V. (NasdaqGS:PHVS) is a clinical-stage company focused on bringing oral bradykinin-B2-receptor antagonists to patients. By targeting this clinically proven therapeutic target with novel small molecules, the Pharvaris team is advancing new alternatives to injected therapies for all sub-types of HAE and other bradykinin-mediated diseases. The Company brings together executives with a breadth of expertise across pharmaceutical development and rare disorders, including HAE.

 

Evaxion Biotech A/S (NasdaqGS:EVAX) is a clinical-stage AI-immunology™ platform company decoding the human immune system to discover and develop novel immunotherapies to treat cancer, bacterial diseases and viral infections. Based on its proprietary and scalable AI-immunology core technology, Evaxion is developing a broad pipeline of novel product candidates which currently includes three patient-specific cancer immunotherapies, two of which are in Phase 1/2a clinical development. In addition, Evaxion is advancing a portfolio of vaccines to prevent bacterial and viral infections currently in preclinical development.

 

Angion Biomedica Corp. (NasdaqGS:ANGN) is committed to transforming the treatment paradigm for patients suffering from acute organ injuries and fibrotic diseases for which there are no approved medicines or where existing approved medicines have limitations. Angion’s lead product candidate, ANG-3777, is a hepatocyte growth factor (HGF) mimetic currently being evaluating in a Phase 3 registration trial for delayed graft function in patients undergoing deceased donor kidney transplantation, a Phase 2 trial in cardiac-surgery associated acute kidney injury, and a Phase 2 trial in patients with COVID-19 related pneumonia at high risk for acute respiratory distress syndrome. Angion is also currently evaluating ANG-3070, a tyrosine kinase receptor inhibitor for the treatment of fibrotic disease, in Phase 1. Additionally, Angion has preclinical programs for a rho kinase 2 (ROCK2) inhibitor and a CYP11B2 (aldosterone synthase) inhibitor.

 

Immunocore Holdings plc (NasdaqGS:IMCR) is a late-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies called ImmTAX – Immune mobilizing monoclonal TCRs Against X disease – designed to treat a broad range of diseases, including cancer, infectious and autoimmune. Leveraging its proprietary, flexible, off-the-shelf ImmTAX platform, Immunocore is developing a deep pipeline in multiple therapeutic areas, including five clinical stage programs in oncology and infectious disease, advanced pre-clinical programs in autoimmune disease and multiple earlier pre-clinical programs. Immunocore’s most advanced oncology therapeutic candidate, tebentafusp, has demonstrated an overall survival benefit in a randomized Phase 3 clinical trial in metastatic uveal melanoma, a cancer that has historically proven to be insensitive to other immunotherapies.

 

Bolt Biotherapeutics, Inc. (NasdaqGS:BOLT) is a clinical-stage biotechnology company pioneering a new class of immuno-oncology agents that combine the targeting precision of antibodies with the power of both the innate and adaptive immune systems Bolt’s proprietary Boltbody™ Immune-stimulating Antibody Conjugates (ISACs) approach uses immunostimulants to engage and activate myeloid cells that directly kill tumor cells. This leads to the conversion of immunologically “cold” tumors to “hot” tumors. Bolt’s lead candidate, BDC-1001, is a Boltbody ISAC comprised of a HER2-targeting biosimilar of trastuzumab conjugated to one of Bolt’s proprietary TLR7/8 agonists for the treatment of patients with HER2-expressing solid tumors. Bolt is also advancing additional Boltbody ISAC product candidates targeting CEA and PD-L1.

 

Defence Therapeutics Inc. (CSE:DTC)  is a biotechnology company engaged in the business of research and development, focusing on enhancing delivery of tumor-/ and infectious disease-specific therapeutics. The principal business carried on is the development of a biological drug enhancer platform that improves the efficacy and safety of a multitude of biological/biosimilar-based pharmaceuticals used in the treatment of cancer and infectious diseases.

 

Theralink Technologies Inc. (OTC:OBMP) is a proteomics-based, molecular profiling and precision medicine company with a CLIA-certified laboratory located in Golden, Colorado. Through its unique and patented phosphoprotein and protein biomarker platform and LDTs, Theralink's technology targets multiple areas of oncology and drug development. Theralink provides precision oncology data through its powerful Theralink® Reverse Phase Protein Array assays to assist the biopharmaceutical industry and clinical oncologists in identifying likely responders and non-responders to both FDA-approved and investigational drug treatments. Theralink intends to help improve cancer outcomes for patients, help reveal therapeutic options for oncologists, and support biopharmaceutical drug development by using a beyond-genomics approach to molecular profiling that directly measures drug target levels and activity.

 

Lucira Health, Inc. (NasdaqGS:LHDX) is a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits. Lucira’s testing platform produces lab quality molecular testing in a single-use, consumer-friendly, palm size test kit powered by two AA batteries. Lucira designed its test kits to provide accurate, reliable and on-the-spot molecular tests results anywhere and anytime. The LUCIRA CHECK IT (OTC) and LUCIRA COVID-19 All-In-One Test Kits (RX) are designed to provide a clinically relevant COVID-19 result within 30 minutes from sample collection.

 

Wesana Health (CSE:WESA) is an emerging life sciences company championing the development and delivery of psychedelic and naturally-sourced therapies to treat traumatic brain injury (TBI). Through extensive clinical research and academic partnerships, Wesana Health is developing evidence-based formulations and protocols that empower patients to overcome neurological, psychological and mental health ailments caused by trauma.

 

New Stocks added to Mining Stocks Directory:

TomaGold Corp (TSX-V:LOT) is a Canadian mineral exploration corporation engaged in the acquisition, assessment, exploration and development of gold mineral properties. TomaGold has interests in five gold properties near the Chibougamau mining camp in northern Quebec: Obalski, Monster Lake East, Monster Lake West, Hazeur and Lac Doda. It also participates in a joint venture with Evolution Mining Ltd. and New Gold Inc., through which it holds a 24.5% interest in the Baird property, near the Red Lake mining camp in Ontario.

 

Canterra Minerals (TSXV: CTM, OTC: CTMCF) is earning a 100% interest in the Wilding and Noel Paul Gold Projects, located 50km south, by logging road, from Millertown and directly northeast of Marathon Gold’s Valentine Lake Gold Project in Central Newfoundland. The 243km2 property package includes 50km of the northeastern strike-extension of the Rogerson Lake Structural Corridor, which hosts Marathon Gold’s Valentine Lake deposits, Matador Mining’s Cape Ray deposit, Sokoman’s Moosehead discovery and TRU Precious Metals’ Golden Rose and Twilight discoveries. A $2.75 million exploration program is underway, focusing on drilling and surface exploration on the Wilding Gold Project. This program will include additional diamond drilling on the existing zones and follow up trenching and diamond drilling on numerous targets identified from previous soil geochemistry sampling. Canterra’s team has more than 100 years of experience searching for gold and diamonds in Canada and have been involved in the discovery of the Snap Lake diamond mine, in addition to the discovery of the Blackwater Gold deposit in British Columbia, Canada.

 

Nevada Silver Corporation (TSXV: NSC) (TSXV: NBS.P) is a mineral exploration company with its material asset being the 100% owned Corcoran Canyon Silver Project in Nevada. The Corporation also holds a manganese project in Minnesota, USA.

 

New Stocks added to Tech Stocks Directory:

Transphorm Inc. (OTC:TGAN) a global leader in the GaN revolution, designs and manufactures high performance and high reliability GaN semiconductors for high voltage power conversion applications. Having one of the largest Power GaN IP portfolios of more than 1,000 owned or licensed patents, Transphorm produces the industry’s first JEDEC and AEC-Q101 qualified high voltage GaN semiconductor devices. The Company’s vertically integrated device business model allows for innovation at every development stage: design, fabrication, device, and application support. Transphorm’s innovations are moving power electronics beyond the limitations of silicon to achieve over 99% efficiency, 40% more power density and 20% lower system cost. Transphorm is headquartered in Goleta, California and has manufacturing operations in Goleta and Aizu, Japan

 

New Stocks added to Green Stocks Directory:

Taronis Fuels (OTC:TRNF) is a global producer of renewable and socially responsible fuel products. Taronis is dedicated to providing safe solutions to meet the industrial, commercial and residential needs of tomorrow’s global economy.

 

The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

 

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood, Acorn, Stash and others.

 

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news and press releases, research and our own original financial content. We were one of the first retail investor sites to cover renewable energy and cleantech stocks at investorideas.com and our domain Renewableenergystocks.com. We were also one of the most well- known and cited defense stock sites, featuring our domain Homelanddefensestocks.com at its peak.

We follow the money for investors as sector sentiment shifts and technology disrupts. Our mission is to provide investor ideas with breaking news, resources, industry articles and interviews with leading experts.      

 

Learn about investing in stocks and sector trends with our news alerts, articles,  podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea's original branded content includes the following podcasts and columns: Crypto Corner, Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change, Exploring Mining and the AI Eye.

 

Public companies within the sectors we cover use our news and content services to tell their story to interested investors. Paid for content is disclosed.  

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Learn more about our news, PR and social media, podcast and ticker tag services at Investorideas.com

https://www.investorideas.com/Investors/Services.asp

 

Learn more about advertising and guest posts

https://www.investorideas.com/Advertise/

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android  

 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 

 

 

#AI #Stock News - GBT (OTC: $GTCH) is integrating xCalibre Image Analysis To Work With Its Long-Range Radio System; #ArtificialIntelligence

#AI #Stock News - GBT (OTC: $GTCH) is integrating xCalibre Image Analysis To Work With Its Long-Range Radio System; #ArtificialIntelligence

 

Potentially Enabling Around The Globe Intelligent Surveillance And Image Analysis

 

 

San Diego, CA, May 13, 2021 - (Investorideas.com Newswire) GBT Technologies Inc. (OTC PINK: GTCH) ("GBT”, or the “Company”), is integrating its xCalibre image analysis into its long range radio Infinia system. GBT’s xCalibre (internal project name) is an advanced, real-time, image analysis and recognition conceptual system. Upon full development, xCalibre is intended to offer smart detection and recognition functions with CCTV (Closed Circuit TV) cameras, recorded videos and images. xCalibre is intended to make it possible to collect and analyze information in real-time, identify humans and objects. The system will be based on GBT’s AI technology and is intended to be able to identify persons-of-interest and/or specific objects. xCalibre’s goal is to identify humans, with or without facial and body covers, and concealed objects of interest. The system will include an advanced cybersecurity protocol to keep all data secured and is based on the company’s recent filed image recognition patent.

 

Read this news, featuring GTCH in full at https://www.investorideas.com/CO/GOPH/news/2021/05131xCalibre-Image-Analysis.asp

 

The Infinia project (internal project name) – is an on-going development, a high performance, fully integrated, radio transceiver system that is ideally suited for applications that require long range data and audio communication and network robustness. In order to support xCalibre real-time image analysis, Infinia is designed to deliver a high GBPS (Gigabytes per Second) bandwidth, with ultra-low latency (Processing a very high volume of data messages with minimal delay), very similar to 5G networks. GBT intends to integrate the two systems together to enable real-time image recognition and analysis for remote locations. The Infinia is targeted to support surveillance cameras to transmit video and audio signals via radio waves technology to xCalibre system that will be processing the data, and performing image recognition from anywhere around the world. GBT believes that this can open new business horizons, enabling intelligent surveillance and imaging analysis anywhere around the globe.

 

There is no guarantee that the Company will be successful in researching, developing or implementing this system.  In order to successfully implement this concept, the Company will need to raise adequate capital to support its research and, if successfully researched, developed and granted regulatory approval, the Company would need to enter into a strategic relationship with a third party that has experience in manufacturing, selling and distributing this product.  There is no guarantee that the Company will be successful in any or all of these critical steps. 

 

About Us

GBT Technologies, Inc. (OTC PINK: GTCH) (“GBT”) (http://gbtti.com) is a development stage company which considers itself a native of Internet of Things (IoT), Artificial Intelligence (AI) and Enabled Mobile Technology Platforms used to increase IC performance. GBT has assembled a team with extensive technology expertise and is building an intellectual property portfolio consisting of many patents. GBT’s mission, to license the technology and IP to synergetic partners in the areas of hardware and software. Once commercialized, it is GBT’s goal to have a suite of products including smart microchips, AI, encryption, Blockchain, IC design, mobile security applications, database management protocols, with tracking and supporting cloud software (without the need for GPS). GBT envisions this system as a creation of a global mesh network using advanced nodes and super performing new generation IC technology. The core of the system will be its advanced microchip technology; technology that can be installed in any mobile or fixed device worldwide. GBT’s vision is to produce this system as a low cost, secure, private-mesh-network between any and all enabled devices. Thus, providing shared processing, advanced mobile database management and sharing while using these enhanced mobile features as an alternative to traditional carrier services.

Forward-Looking Statements

Certain statements contained in this press release may constitute "forward-looking statements".  Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website ( http://www.sec.gov).  In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company’s ability to raise capital on acceptable terms, if at all, the Company’s successful development of its products and the integration into its existing products and the commercial acceptance of the Company’s products.  The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change.  However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so.  These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release.

 

Contact:

Dr. Danny Rittman, CTO
press@gopherprotocol.com

 

GBT Technologies Inc. (OTCQB:GTCH) is a featured tech stock on

Investorideas.com

 

More info on GTCH at Investorideas.com Visit: https://www.investorideas.com/CO/GOPH/

 

Get News Alerts on GBT Technologies Inc GTCH

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure: GTCH is a PR, social media and publishing client and compensates Investorideas.com https://www.investorideas.com/About/News/Clientspecifics.asp Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com  Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

  Get more tech stocks investor ideas- news, articles, podcasts and stock directories

 

 

#AIEye #Podcast 555- #Stocks discussed: (OTCPINK: $GTCH) (NYSE: $SLB) (NYSE: $NOV); #Artificialintelligence

 

 

 

#AIEye #Podcast 555- #Stocks discussed: (OTCPINK: $GTCH) (NYSE: $SLB) (NYSE: $NOV); #Artificialintelligence

 

GBT Files Patent for IC Reliability Verification Analysis, and Schlumberger Announces Collaboration with NOV

 

Global Neuromorphic Computing Market to Reach $550.593M by 2026

 

Point Roberts WA, Vancouver BC – May 12, 2021  – Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of  The AI Eye-  watching stock news, deal tracker and advancements in artificial intelligence  –  featuring technology company GBT Technologies Inc. (OTCPINK:GTCH).

 

Listen to today’s podcast:

https://www.investorideas.com/Audio/Podcasts/2021/051221-AI-Eye.mp3

 

Read this in full at https://www.investorideas.com/news/2021/artificial-intelligence/05121GTCH-SLB-NOV.asp

 

Hear the Ai Eye on Spotify  

 

Today’s Column- The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence

 

Stocks discussed: (OTCPINK:GTCH) (NYSE:SLB) (NYSE:NOV)

 

GBT Technologies Inc. (OTC PINK:GTCH) has filed a patent application with the United States Patent and Trademark Office (USPTO) covering Integrated Circuits reliability verification analysis. Empowered by the company's AI capabilities for rapid image recognition and vast data analysis, the patent seeks to protect systems and methods to check and correct microchips layout for reliability violations. GBT’s CTO, Danny Rittman, explained:

 

"Advanced integrated circuits mask layout design is becoming more challenging particularly due to the fact that geometries are getting smaller and more complex. Microchips’ reliability models are based on physics-of-failure mechanisms and as manufacturing processes go smaller electrical issues significantly rise. The industry is continuously scaling down semiconductor feature sizes which raises challenges in developing reliable electronic circuits with the constant demand for lower power consumption and more features. We have developed a system and method with the intended goal to analyze IC mask layout data for reliability issues, identifying "weak-spots" that are prone for failure."

 

Schlumberger Limited (NYSE:SLB) has announced a collaboration with NOV Inc. (NYSE:NOV) to accelerate automated drilling solutions adoption by oil and gas operators and drilling contractors. Advanced AI from the Schlumberger DrillOps on-target well delivery solution works with NOV’s NOVOS process-automation platform controls “to manage compliance to procedure and to reach best-in-class operational performance.” Olivier Le Peuch, CEO, Schlumberger, said:

 

"We are pleased to collaborate with NOV and to integrate their rig automation interface with our drilling automation solutions to unlock higher performance for operators and drilling contractors. Leveraging downhole and surface automation applications, we can deliver enhancements in operations safety and efficiency, and deliver top-quartile wells for our customers consistently. This partnership will help accelerate customers’ adoption of drilling automation technologies, enabling superior well construction performance."

 

Global Neuromorphic Computing Market to Reach $550.593M by 2026

 

A report published by Research and Markets finds that the global Neuromorphic Computing market will grow from $22.743 million in 2021 to $550.593 million by 2026 with a compound annual growth rate (CAGR) of 89.1 percent in that forecast period. An excerpt from the report’s description reads:

 

The need for better performing ICs, increase in demand for artificial intelligence and machine learning, and increasing number of cross-industry partnerships and collaborations are key factors driving the growth of the market. Artificial intelligence (AI) is being adopted in industries such as medical, media, entertainment, telecom, utility, aerospace, military, consumer devices, food & beverages, and piping.

A combination of AI systems and machine learning is set to revolutionize the business environment with smart decisions. However, lack of knowledge about neuromorphic computing and complex algorithms increasing complexity of designing hardware of neuromorphic chips can act as a major challenge in the market during the forecast period.

 

Sam Mowers, Investorideas.com

 

Read and hear other editions of the AI  Eye

 

For a list of artificial intelligence stocks on Investorideas.com visit here

Investors can trade these stocks and other ideas on our site using our  list of top stock trading apps including Robinhood , Acorn, Stash  and others.

 

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

The Investorideas.com podcasts are also available on iTunes ( Apple Podcasts) ,  Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio, Google Play Music and most audio platforms available.

Visit the Podcast page at Investorideas.com:

https://www.investorideas.com/Audio/

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com 

Disclaimer  : GTCH is a paid AI featured stock on Investorideas

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

The AI Eye-  Watching stock news, deal tracker and  advancements in artificial intelligence is an original content brand of Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 

Get more Technology stock investor ideas - news, articles, podcasts and stock directories

#AI #Stock News: GBT (OTC: $GTCH) Filed Patent Application for Integrated Circuit Reliability Verification Analysis; #Artificialintelligence

#AI #Stock News: GBT (OTC: $GTCH) Filed Patent Application for Integrated Circuit Reliability Verification Analysis; #Artificialintelligence

 

#Technology Seeks to Ensure Microchip's Efficient Power Design, Prolonging Life and Avoid Overheat

 

San Diego, CA - May 11, 2021 (Investorideas.com Newswire) GBT Technologies Inc. (OTC PINK: GTCH) ("GBT" or the "Company"), filed with the UNITED STATES PATENT AND TRADEMARK OFFICE ("USPTO") - a patent application covering Integrated Circuits reliability verification analysis. The application has been assigned with the USPTO a serial number 17315747 and the filing date is May 10, 2021.

 

Read this news, featuring GTCH in full at https://www.investorideas.com/CO/GOPH/news/2021/05111Patent-Integrated-Circuit.asp

 

The patent seeks to protect systems and methods to check and correct microchips layout for reliability violations. The underlying technology contemplates allowing IC designers to be able to analyze and fix circuits more efficiently, in real-time, and get visibility into electrical issues early during the design stages. GBT intends to target microchip's early design stages electrical and power analysis in order to identify potential failures and provide an on-the-fly solution with the intended goal of saving weeks to months of engineering design time. The technology underlying the patent is targeted to enhance design team productivity and microchip performance for custom and synthesized ICs by enabling testing and improving/correcting of reliability issues to avoid failures. The technology includes real time electrical analysis capability. The technology is empowered by the company's AI capabilities for rapid image recognition and vast data analysis, especially for advanced manufacturing nodes like 5nm and below. The patent application is targeted for old and new manufacturing technologies, including 7nm, 5nm and below.

 

"Advanced integrated circuits mask layout design is becoming more challenging particularly due to the fact that geometries are getting smaller and more complex. Microchip's reliability models are based on physics-of-failure mechanisms and as manufacturing processes goes smaller electrical issues significantly rise. The industry continuously scaling down semiconductor feature sizes which raises challenges in developing reliable electronic circuits with the constant demand for lower power consumption and more features. We have developed a system and method with the intended goal to analyze IC mask layout data for reliability issues, identifying "weak-spots" that are prone for failure. Giving a simplistic example, if an electrical current is supposed to flow in a chip's metal wire that is too thin, it will melt the wire like a fuse effect. The filed patent describes a real time method to analyze this wire early during the chip's design stage, and alerting the designer to make it wider. In this way the chip's electronic circuits are pre-analyzed by construction, maintaining the chip's reliability and efficient power consumption and distribution which in theory will allow Integrated circuits to function longer, consume less power and overheat less. This invention describes an on-the-fly electrical analysis to enable chip designers to address these reliability issues early during the design stage, keeping their hands on the pulse of the entire project's power management and overall performance." Said Danny Rittman the Company's CTO.

 

There is no guarantee that the Company will be successful in researching, developing or implementing this technology. To successfully implement this concept, the Company will need to raise adequate capital to support its research and, if successfully researched, developed, and granted regulatory approval, the Company would need to enter a strategic relationship with a third party that has experience in manufacturing, selling, and distributing this product. There is no guarantee that the Company will be successful in any or all of these critical steps.

 

About Us

GBT Technologies, Inc. (OTC PINK: GTCH) ("GBT") (http://gbtti.com) is a development stage company which considers itself a native of Internet of Things (IoT), Artificial Intelligence (AI) and Enabled Mobile Technology Platforms used to increase IC performance. GBT has assembled a team with extensive technology expertise and is building an intellectual property portfolio consisting of many patents. GBT's mission, to license the technology and IP to synergetic partners in the areas of hardware and software. Once commercialized, it is GBT's goal to have a suite of products including smart microchips, AI, encryption, Blockchain, IC design, mobile security applications, database management protocols, with tracking and supporting cloud software (without the need for GPS). GBT envisions this system as a creation of a global mesh network using advanced nodes and super performing new generation IC technology. The core of the system will be its advanced microchip technology; technology that can be installed in any mobile or fixed device worldwide. GBT's vision is to produce this system as a low cost, secure, private-mesh-network between all enabled devices. Thus, providing shared processing, advanced mobile database management and sharing while using these enhanced mobile features as an alternative to traditional carrier services.

 

Forward-Looking Statements

Certain statements contained in this press release may constitute "forward-looking statements". Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements because of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website (http://www.sec.gov). In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company's ability to raise capital on acceptable terms, if at all, the Company's successful development of its products and the integration into its existing products and the commercial acceptance of the Company's products. The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release.

 

Contact:

Dr. Danny Rittman, CTO
press@gopherprotocol.com

 

GBT Technologies Inc. (OTCQB:GTCH) is a featured tech stock on

Investorideas.com

 

More info on GTCH at Investorideas.com Visit: https://www.investorideas.com/CO/GOPH/

 

Get News Alerts on GBT Technologies Inc GTCH

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure: GTCH is a PR, social media and publishing client and compensates Investorideas.com https://www.investorideas.com/About/News/Clientspecifics.asp Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com  Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

  Get more tech stocks investor ideas- news, articles, podcasts and stock directories